Argatroban versus heparin in patients without heparin-induced thrombocytopenia during venovenous extracorporeal membrane oxygenation: a propensity-score matched study

BACKGROUND: During venovenous extracorporeal membrane oxygenation (vvECMO), direct thrombin inhibitors are considered by some potentially advantageous over unfractionated heparin (UFH). We tested the hypothesis that Argatroban is non-inferior to UFH regarding thrombosis and bleeding during vvECMO. M...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Crit Care
Hlavní autoři: Fisser, Christoph, Winkler, Maren, Malfertheiner, Maximilian V., Philipp, Alois, Foltan, Maik, Lunz, Dirk, Zeman, Florian, Maier, Lars S., Lubnow, Matthias, Müller, Thomas
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2021
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8081564/
https://ncbi.nlm.nih.gov/pubmed/33910609
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-021-03581-x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky